A PHASE I/II CLINICAL TRIAL OF ALLOGENEIC EX VIVO EXPANDED CORNEAL EPITHELIAL STEM CELLS IN PATIENTS WITH SEVERE OCULAR SURFACE DISORDER ARISING FROM LIMBAL STEM CELL DEFICIENCY

被引:0
|
作者
Turner, M. [1 ]
Bienek, C. [1 ]
McGowan, N. [1 ]
Dhillon, B. [2 ]
Campbell, J. [1 ]
Glover, A. [1 ]
机构
[1] SNBTS, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[3] NHS Lothian, Edinburgh, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
326
引用
收藏
页码:S134 / S134
页数:1
相关论文
共 50 条
  • [31] Letter Regarding: Why Are Corneal Specialists Resistant to Treating Patients Who Have Severe Ocular Surface Disease with Limbal Stem Cell Deficiency? Reply
    Holland, Edward J.
    Cheung, Albert Y.
    Djalilian, Ali R.
    CORNEA, 2024, 43 (02) : E1 - E3
  • [32] Standardized cultivation and transplantation of limbal stem cell grafts: Results of a phase I/II clinical trial
    Zakaria, Nadia
    Possemiers, Tine
    Leysen, Inge
    Rozema, Jos
    Koppen, Carina
    Berneman, Zwi
    Tassignon, Marie-Jose
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [33] Therapeutic Potential of Hair Follicle-Derived Epithelial Stem Cells for Ocular Surface Reconstruction Using a Murine Limbal Stem Cell Deficiency Model
    Meyer-Blazejewska, E. A.
    Liu, H.
    Call, M. K.
    Schlotzer-Schrehardt, U.
    Kao, W. W.
    Kruse, F. E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [34] Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/II Clinical Trial in Progress
    Hagiwara, Shotaro
    Wang, Yan-Hua
    Kobayashi, Hirohito
    Kato, Yutaka
    Tanaka, Norina
    Iizuka, Yuki
    Watanabe, Aya
    Ishiyama, Midori
    Shinohara, Akihito
    Kazama, Hiroshi
    Yoshinaga, Kentaro
    Shiseki, Masayuki
    Kanno, Hitoshi
    Tanaka, Junji
    BLOOD, 2019, 134
  • [35] Ocular Surface Microbial Flora in Patients with Chronic Limbal Stem Cell Deficiency Undergoing Cultivated Oral Mucosal Epithelial Transplantation
    Gunasekaran, Srilathaa
    Dhiman, Rebika
    Vanathi, Murugesan
    Mohanty, Sujatha
    Satpathy, Gita
    Tandon, Radhika
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2019, 26 (01) : 23 - 26
  • [36] Ex vivo hematopoietic stem cell cord cryopreserved for allogeneic treatment: Validation in GMP conditions of phase I/II clinical protocol
    Gunetti, M.
    Ferrero, I
    Rustichelli, D.
    Berger, M.
    Gammaitoni, L.
    Timeus, F.
    Piacibello, W.
    Aglietta, M.
    Fagioli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 14 - 15
  • [37] ESTABLISHMENT OF A LICENSED CORNEAL EPITHELIAL STEM CELL CLINICAL PRODUCT FOR USE IN THE TREATMENT OF PATIENT WITH SEVERE OCULAR SURFACE DISEASE
    Bienek, C.
    Atkinson, A.
    Bailey, L.
    Barry, J.
    Drain, J.
    Cuthbertson, B.
    Pelly, J.
    McQuillan, T.
    Galea, G.
    McGowan, N.
    Campbell, J.
    MacDonald, M.
    Agrawal, A.
    Ramaesh, K.
    Mantry, S.
    Ahmad, S.
    Kaye, S.
    Dhillon, B.
    Turner, M.
    CYTOTHERAPY, 2014, 16 (04) : S107 - S108
  • [38] Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: Update on phase I/II clinical trial
    Kinsella, Jane Louise
    Jones, Simon
    Thrasher, Adrian J.
    Booth, Claire
    Buckland, Karen F.
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather J.
    Tylee, Karen L.
    Brammeier, Kathryn L.
    Jones, Ceri
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Ellison, Stuart
    Bigger, Brian W.
    Wynn, Robert F.
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S56 - S57
  • [39] Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation
    Zakaria, Nadia
    Possemiers, Tine
    Dhubhghaill, Sorcha Ni
    Leysen, Inge
    Rozema, Jos
    Koppen, Carina
    Timmermans, Jean-Pierre
    Berneman, Zwi
    Tassignon, Marie-Jose
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [40] Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation
    Zakaria, N.
    Koppen, C.
    Tassignon, M. J.
    ACTA OPHTHALMOLOGICA, 2013, 91